hotspot -WSS

hotspot

author：fashion 2025-09-06 05:03:12 - browse：4

STAT's Damian Garde speaks with Mikael Dolsten and Mathai Mammen, in New York on March 21, 2024 — From left to right, STAT's Damian Garde; Mikael Dolsten, chief scientific officer of Pfizer research and development; and Rose Loughlin, Moderna’s senior vice president of early research and development, discuss the future of pharma at the STAT 2024 Breakthrough Summit East. STAT

Drug development is more of a sprint than a marathon these days, thanks to more and better ways to target underlying biology and a more nuanced interpretation of precision medicine, three biotech leaders said at the STAT Breakthrough Summit East in New York Thursday.

“We used to say, well, you may spend five years in the research phase, another five in development. Now I see a project that takes one year of research, from an idea to studies,” said Mikael Dolsten, chief scientific officer and president of Pfizer research and development. “Time is life. You care about patients. And when the distance to run is long, it holds back the energy and the inspiration.”

Key to that success are transformative new technologies like messenger RNA, which powered vaccines developed by Pfizer with its partner BioNTech.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： After Sarepta trial failure, Duchenne families brace for more debate

knowledge

WSS

Life sciences investors close nearly $6 billion in new funds

Gene therapy’s promise and the high cost of hope

Louisiana bill approved classifying abortion pills as controlled substances

Lung cancer screening guidelines updated for cigarette smokers

Why some fertility treatments produce more boy babies

Ozempic cut risk of death in diabetes patients with chronic kidney disease

entertainment

hotspot

hotspot

Heart attack and stroke risk calculators need revising

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Supreme Court strikes down use of affirmative action

Gene therapy’s promise and the high cost of hope

In age of alternative facts, a scholarly course on calling out crap

Should insurance cover cosmetic surgery?

Dobbs anniversary: the lost opportunity of abortion as health care

Prime Medicine says its gene editing passes test in monkeys

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Kidney transplant patients stopped immunosuppressants in trial

knowledge

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

Why some fertility treatments produce more boy babies

All of Us, NIH's precision medicine initiative, gets a big boost

Key Senate panel to consider PBM, drug pricing reform package

leisure time

knowledge

knowledge

knowledge